Association and risk of hypercholesterolemia among patients with prediabetes from a medical center in Villa El Salvador, Lima, Peru
DOI:
https://doi.org/10.24265/horizmed.2024.v24n2.01Keywords:
Hyperglycemia , Hypercholesterolemia , Odds Ratio , Blood Glucose , Chi-Square DistributionAbstract
Objective: To evaluate the association and risk of hypercholesterolemia among adult patients with prediabetes treated at a medical center in the district of Villa El Salvador in Lima, Peru. Materials and methods: An analytical, prospective and cross-sectional study conducted with data from medical consultation records of 749 patients treated at a polyclinic in the district of Villa El Salvador in Lima, Peru. Asymptomatic adult patients who had routine and preventive checkups were included in the research. Patients with endocrine and metabolic disorders or being treated with hypoglycemic drugs were excluded. The study variables were sex, hypercholesterolemia and prediabetes. The association analysis was performed using the chi-square test and the risk was evaluated by means of the odds ratio. In addition, the multivariate analysis was conducted through a binary logistic regression, and an alpha value of 0.05 and a confidence level of 95 % were considered as the cut-off point to determine the statistical significance. Results: There was a statistically significant association between prediabetes and hypercholesterolemia. Females with prediabetes were 1.66 times more likely to develop hypercholesterolemia than females with normal baseline glucose levels, while males with prediabetes were 2.37 times more likely to have high cholesterol than males with normal baseline blood glucose levels. Conclusions: Prediabetes is associated with hypercholesterolemia, thus increasing its risk. It is justifiable to carry out the joint measurement of fasting total cholesterol and baseline glucose in disease prevention and health promotion campaigns, regular checkups and follow-up of patients with risk factors for diabetes, prediabetes and hypercholesterolemia. This helps reduce the hemodynamic and cardiovascular consequences of high cholesterol levels and the worsening of the joint morbidity and mortality of chronic hyperglycemia.
Downloads
References
Álvarez S, Coffey R, Algotar A. Prediabetes [Internet]. Stat Pearls; 2022. Disponible en: https://www.statpearls.com/ArticleLibrary/ viewarticle/27611
Buitrago-Gómez N, Figueroa L, Casanova ME. La prediabetes y su impacto sobre la salud cardiovascular: artículo de revisión. Univ Salud [Internet]. 2022;24(2):170–83.
Luís C, Soares R, Baylina P, Fernandes R. Underestimated prediabetic biomarkers: Are we blind to their strategy? Front Endocrinol (Lausanne) [Internet]. 2022;13:805837.
Schlesinger S, Neuenschwander M, Barbaresko J, Lang A, Maalmi H, Rathmann W, et al. Prediabetes and risk of mortality, diabetesrelated complications and comorbidities: umbrella review of meta-analyses of prospective studies. Diabetologia [Internet]. 2022;65(2):275–85.
Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for prediabetes and type 2 diabetes: US preventive services task force recommendation statement. JAMA [Internet]. 2021;326(8):736–43.
Rapoport M, Chetrit A, Cantrell D, Novikov I, Roth J, Dankner R. Years of potential life lost in pre-diabetes and diabetes mellitus: data from a 40-year follow-up of the Israel study on glucose intolerance, obesity and hypertension. BMJ Open Diabetes Res Care [Internet]. 2021;9(1):e001981.
Al-Sharafi BA, Qais AA, Salem K, Bashaaib MO. Family history, consanguinity and other risk factors affecting the prevalence of prediabetes and undiagnosed diabetes mellitus in overweight and obese Yemeni adults. Diabetes Metab Syndr Obes [Internet]. 2021;14:4853–63.
Van Herpt TTW, Ligthart S, Leening MJG, van Hoek M, Lieverse AG, Ikram MA, et al. Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria. BMJ Open Diabetes Res Care [Internet]. 2020;8(2):e001529.
Hostalek U. Global epidemiology of prediabetes - present and future perspectives. Clin Diabetes Endocrinol [Internet]. 2019;5(1):5.
Ibrahim MA, Asuka E, Jialal I. Hypercholesterolemia. StatPearls Publishing; 2022.
Vrablik M, Tichý L, Freiberger T, Blaha V, Satny M, Hubacek JA. Genetics of familial hypercholesterolemia: New insights. Front Genet [Internet]. 2020;11:574474.
Yanai H, Yoshida H. Secondary dyslipidemia: its treatments and association with atherosclerosis. Glob Health Med [Internet]. 2021;3(1):15–23.
Coutinho ER, Miname MH, Rocha VZ, Bittencourt MS, Jannes CE, Tada MT, et al. Familial hypercholesterolemia and cardiovascular disease in older individuals. Atherosclerosis [Internet]. 2021;318:32-7.
Collado A, Domingo E, Piqueras L, Sanz M-J. Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction. Int J Biochem Cell Biol [Internet]. 2021;139(106066):106066.
Björkegren JLM, Lusis AJ. Atherosclerosis: Recent developments. Cell [Internet]. 2022;185(10):1630–45.
Al-Zahrani J, Shubair MM, Al-Ghamdi S, Alrasheed AA, Alduraywish AA, Alreshidi FS, et al. The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a crosssectional survey. BMC Cardiovasc Disord [Internet]. 2021;21(1):22.
Miao Z, Alvarez M, Ko A, Bhagat Y, Rahmani E, Jew B, et al. The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance. PLoS Genet [Internet]. 2020;16(9):e1009018.
Sun J, Liu Z, Zhang Z, Zeng Z, Kang W. The correlation of prediabetes and type 2 diabetes with adiposity in adults. Front Nutr [Internet]. 2022;9:818263.
Trias F, Pintó X, Corbella E, Suárez-Tembra M, Ruíz-García A, DíazDíaz JL, et al. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study. Med Clin (Barc) [Internet]. 2022;158(11):531–9.
Park JY, Ghazi A, Pittas AG, Vickery E, Nelson JP, Aroda VR, et al. 854-P: Statin use and new-onset diabetes in people with prediabetes. Diabetes [Internet]. 2022;71(1):854.
Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: The epidemiological evidence. Annu Rev Public Health [Internet]. 2021;42(1):59–77.
Málaga G, Zevallos-Palacios C, Lazo M de LÁ, Huayanay C. Elevada frecuencia de dislipidemia y glucemia basal alterada en una población peruana de altura. Rev Peru Med Exp Salud Publica [Internet]. 2010;27(4):557–61.
American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in diabetes-2021. Diabetes Care [Internet]. 2021;44(Suppl 1):S15–33. Alberto Guevara Tirado
Bello de García MB, Menoni de Lezcano MC, Garcia LB, Centurión OA. Frequency of risk factors for the development of prediabetes in health workers. Rev Virtual Soc Paraguaya Med Interna [Internet]. 2020;7(1):20–9.
Al Amri T, Bahijri S, Al-Raddadi R, Ajabnoor G, Al Ahmadi J, Jambi H, et al. The association between prediabetes and dyslipidemia among attendants of primary care health centers in Jeddah, Saudi Arabia. Diabetes Metab Syndr Obes [Internet]. 2019;12:2735–43.
Arranz-Martínez E, Ruiz-García A, García Álvarez JC, Fernández Vicente T, Iturmendi Martínez N, Rivera-Teijido M, et al. Prevalencia de prediabetes y asociación con factores cardiometabólicos y renales. Estudio SIMETAP-PRED. Clin Investig Arterioscler [Internet]. 2022;34(4):193–204.
Kansal S, Kamble TK. Lipid profile in prediabetes. J Assoc Physicians India. 2016;64(3):18–21.
Bhowmik B, Siddiquee T, Mujumder A, Afsana F, Ahmed T, Mdala IA, et al. Serum lipid profile and its association with diabetes and prediabetes in a rural Bangladeshi population. Int J Environ Res Public Health [Internet]. 2018;15(9).
Sundharan DS, Ramchandran DS, Jatale R. Dyslipidemia in prediabetes population: A retrospective study of 91780 cases. Int J Health Sci Res [Internet]. 2022;12(10):132–9.
Cai X, Zhang Y, Li M, Wu JH, Mai L, Li J, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ [Internet]. 2020;370:m2297.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
